ACG Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$978K Sell
3,002
-204
-6% -$74.9K 0.22% 110
2022
Q2
$1.12M Sell
3,206
-96
-3% -$39.1K 0.23% 104
2022
Q1
$1.81M Sell
3,302
-3,525
-52% -$1.85M 0.34% 81
2021
Q4
$4.5M Sell
6,827
-3,350
-33% -$2.1M 0.64% 47
2021
Q3
$6.33M Sell
10,177
-270
-3% -$181K 0.83% 35
2021
Q2
$6.6M Sell
10,447
-295
-3% -$163K 0.84% 32
2021
Q1
$5.26M Sell
10,742
-55
-0.5% -$27.6K 0.7% 42
2020
Q4
$5.4M Sell
10,797
-65
-0.6% -$29.1K 0.75% 37
2020
Q3
$4.27M Sell
10,862
-232
-2% -$85.8K 0.64% 49
2020
Q2
$3.66M Buy
11,094
+23
+0.2% +$6.66K 0.6% 54
2020
Q1
$2.68M Sell
11,071
-454
-4% -$118K 0.5% 63
2019
Q4
$3.01M Buy
11,525
+40
+0.3% +$10.5K 0.45% 60
2019
Q3
$3.12M Sell
11,485
-2,485
-18% -$692K 0.46% 59
2019
Q2
$3.85M Sell
13,970
-1,735
-11% -$427K 0.52% 53
2019
Q1
$3.51M Buy
15,705
+9
+0.1% +$1.86K 0.47% 54
2018
Q4
$2.92M Hold
15,696
0.45% 59
2018
Q3
$3.92M Sell
15,696
-28
-0.2% -$6.8K 0.52% 48
2018
Q2
$3.43M Sell
15,724
-75
-0.5% -$15.5K 0.52% 50
2018
Q1
$3.02M Buy
15,799
+217
+1% +$40K 0.46% 61
2017
Q4
$2.44M Sell
15,582
-39
-0.2% -$6.14K 0.36% 74
2017
Q3
$2.43M Sell
15,621
-99
-0.6% -$15.7K 0.42% 64
2017
Q2
$2.54M Buy
15,720
+680
+5% +$110K 0.42% 66
2017
Q1
$2.33M Buy
+15,040
New +$2.07M 0.43% 72

Other funds holding IDXX

ACG Wealth's IDXX Position: Q3 2022 in Review

ACG Wealth reduced its Idexx Laboratories (IDXX) stake by 6.4% in Q3 2022, selling an estimated $74.9K and leaving 3,002 shares worth $978K. The position accounts for 0.22% of the portfolio, ranked #110.

ACG Wealth first reported a position in IDXX in Q1 2017 and has held it in 23 quarters since. The position peaked at $6.6M in Q2 2021. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • ACG Wealth held 3,002 shares of Idexx Laboratories worth $978K as of Q3 2022.
  • ACG Wealth sold 204 Idexx Laboratories shares in Q3 2022, an estimated $74.9K.
  • Idexx Laboratories made up 0.22% of ACG Wealth's portfolio in Q3 2022, its #110 holding.
  • ACG Wealth first reported a position in Idexx Laboratories in Q1 2017 and has held it in 23 quarters since.
  • ACG Wealth's Idexx Laboratories position peaked at $6.6M in Q2 2021.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.